Cellectricon have announced that they will be incorporating Tecella’s Richmond patch clamp amplifier in next generation Dynaflow HT platform
Filed under: Uncategorized | Tagged: Cellectricon, Licensing, preclinical, Research, Tecella | Leave a Comment »
Merck Serono have signed a development and licensing agreement for Bionomics Kv1.3 program. Drug candidates have potential in the treatment of Multiple Sclerosis
Filed under: Potassium Channel | Tagged: Bionomics, K Channel, Kv1.3, Licensing, Merck-Serono | Leave a Comment »
Pipex have licensed the oral flupirtine (Effirma) Patent Estate from McLean Hopsital for Diabetes, Diabetic Retinopathy, Retinitis Pigmentosa and Glaucoma. Pipex had already licensed the flupirtine patents for fibromyalgia
Filed under: Potassium Channel | Tagged: antagonist, K Channel, Licensing, NMDA, Pipex, Potassium Channel | Leave a Comment »
Forest has terminated it’s co-promotion agreement for Azor (amlodipine and olmesartan medoxomil) with Daiichi Sankyo. Forest has determined that its resources will be better utilized in providing additional support for Forest’s currently marketed products.
Filed under: Calcium Channel, Ion Channel | Tagged: Amlodipine, Angiotensin II AT1, antagonist, Azor, ca channel, Daiichi-Sankyo, Forest, Licensing, Olmesartan | Leave a Comment »
